Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The sixth Annual Meeting of the Society of Hematologic Oncology (SOHO 2018) took place on September 12–15, 2018, in Houston, TX.

Highlights from this year's SOHO Annual Meeting include clinical updates on leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, lymphomas and other related malignancies.

SOHO 2018

12–15 September 2018 | Houston, TX

SOHO 2018

12–15 September 2018 | Houston, TX

The sixth Annual Meeting of the Society of Hematologic Oncology (SOHO 2018) took place on September 12–15, 2018, in Houston, TX.

Highlights from this year's SOHO Annual Meeting include clinical updates on leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, lymphomas and other related malignancies.

How reliable is NGS in diagnosing AML? 0:57
How reliable is NGS in diagnosing AML?
Christopher Gibson • 12 Sep 2018
The impact of MRD as a biomarker 3:22
The impact of MRD as a biomarker
Nathan Fowler • 12 Sep 2018
MRD in lymphoma 2:30
MRD in lymphoma
Stephen Ansell • 12 Sep 2018
Brentuximab vedotin for treating Hodgkin Lymphoma 2:30
Brentuximab vedotin for treating Hodgkin Lymphoma
Stephen Ansell • 12 Sep 2018
CAR T-cell therapy in B-cell malignancies 2:19
CAR T-cell therapy in B-cell malignancies
Stephen Ansell • 28 Sep 2018
The potential of anti-amyloid antibodies to treat amyloidosis 4:07
The potential of anti-amyloid antibodies to treat amyloidosis
Suzanne Lentzsch • 12 Sep 2018
IMiDs induce hematopoietic malignancies 3:21
IMiDs induce hematopoietic malignancies
Suzanne Lentzsch • 12 Sep 2018
Identifying genetic mutations for diagnosing MDS 2:45
Identifying genetic mutations for diagnosing MDS
Torsten Haferlach • 12 Sep 2018
Personalized therapy for MDS: Advancements and the future 5:06
Personalized therapy for MDS: Advancements and the future
Torsten Haferlach • 12 Sep 2018
Molecular background studies to aid diagnosis and treatment of MDS 2:47
Molecular background studies to aid diagnosis and treatment of MDS
Torsten Haferlach • 12 Sep 2018
Promising therapeutic developments for Hodgkin lymphoma 3:00
Promising therapeutic developments for Hodgkin lymphoma
Stephen Ansell • 12 Sep 2018
Gene-based treatments show positive outcomes in AML 4:42
Gene-based treatments show positive outcomes in AML
Harry Erba • 12 Sep 2018
Limitations of targeted therapy for AML 4:31
Limitations of targeted therapy for AML
Harry Erba • 12 Sep 2018
The earlier the better: detecting target genes in myeloproliferative neoplasms 4:03
The earlier the better: detecting target genes in myeloproliferative neoplasms
Srdan Verstovsek • 12 Sep 2018
Improved understanding of CTCL disease biology 3:09
Improved understanding of CTCL disease biology
Pierluigi Porcu • 12 Sep 2018
Challenges in diagnosing and treating CTCL 2:46
Challenges in diagnosing and treating CTCL
Pierluigi Porcu • 12 Sep 2018

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals